Infoscience

Patent

Nanoparticles for immunotherapy

Nanoparticles that activate complement in the absence of biological molecules are described. The nanoparticles are shown to specifically target antigen presenting cells in specifically in lymph nodes, without the use of a biological molecule for targeting. These particles are useful vehicles for delivering immunotherapeutics.

    Reference

    Record created on 2015-09-22, modified on 2016-08-09

Fulltext

  • There is no available fulltext. Please contact the lab or the authors.

Related material